Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP982679priorityCriticalpatent/ECSP982679A/en
Publication of ECSP982679ApublicationCriticalpatent/ECSP982679A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La invención se refiere a formulaciones medicamentosas que contienen el ácido 1-ciclopropil-7(S,S)-2,8 diazabiciclo (4,3,0) non-8-il)-6-flúor-1,4-dihidro-8-metoxi-4-oxo-3-quinoloncarboxílico y/o sales farmacéuticamente aceptables del mismo y/o hidratos del mismo como sustancia activa, que entregan la sustancia conteniendo con una liberación definida.The invention relates to medicinal formulations containing 1-cyclopropyl-7 (S, S) -2.8 diazabicyclo (4,3,0) non-8-yl) -6-fluoro-1,4-dihydro- 8-methoxy-4-oxo-3-quinolonecarboxylic and / or pharmaceutically acceptable salts thereof and / or hydrates thereof as the active substance, which deliver the containing substance with a defined release.
ECSP9826791998-09-241998-09-24
DRUG FORMULATION WITH CONTROLLED RELEASE OF ACTIVE SUBSTANCE
ECSP982679A
(en)
DERIVATIVES OF TER.-BUTIL- (7-METHYL-IMIDAZO [1,2, a] PIRIDIN-3-IL) -AMINA, PROCEDURE FOR THEIR PREPARATION, DRUGS THAT CONTAIN THEM, THEIR USE FOR THE PREPARATION OF A MEDICATION FOR THE INHIBITION OF NON-SYNTHEASE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CONTROLLED RELEASE MICROGRANULES CONTAINING CISPLATINE, PROCEDURE FOR ITS PREPARATION, PHARMACEUTICAL COMPOSITION AND USE IN THE MANUFACTURE OF A POLYCHIMOTHERAPY MEDICATION OR IN ASSOCIATION WITH RADIOTHERAPY.